action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,,39956,[],CHEMBL759511,The compound was evaluated for antagonist activity against recombinant human P2X purinoceptor 1 (P2X1 ),F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)c1)Nc1cccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,CHEMBL1135773,J Med Chem,2002,,CHEMBL216504,,CHEMBL1206126,6.68,0,http://www.openphacts.org/units/Nanomolar,252102,=,1,1,=,,IC50,nM,,210.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,nM,UO_0000065,,210.0
,,579579,[],CHEMBL759510,Affinity at P2X purinoceptor 1 (P2X1) and the value is expressed as IC50,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL1135726,J Med Chem,2002,"{'bei': '13.97', 'le': '0.30', 'lle': '6.20', 'sei': '2.99'}",CHEMBL129841,,CHEMBL129841,5.94,0,http://www.openphacts.org/units/Nanomolar,346911,=,1,1,=,,IC50,nM,,1150.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,1.15
,,1490082,[],CHEMBL874555,Inhibitory concentration against human P2X purinoceptor 1 (hP2X1) expressed in CHO-K1 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N[C@H](Cc1cscn1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1)c1nc2ccccc2[nH]1,,,CHEMBL1139575,Bioorg Med Chem Lett,2005,,CHEMBL190141,,CHEMBL190141,5.52,0,http://www.openphacts.org/units/Nanomolar,387207,=,1,1,=,,IC50,nM,,3000.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,3.0
,,1610562,[],CHEMBL872176,Inhibitory concentration against human P2X purinoceptor 1 expressed in Xenopus laevis oocytes,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)[O-])c4cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c34)ccc2F)c1)Nc1cccc(C(=O)Nc2cc(C(=O)Nc3ccc(S(=O)(=O)[O-])c4cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c34)ccc2F)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,CHEMBL1140384,J Med Chem,2005,,CHEMBL413145,,CHEMBL1207514,7.20,0,http://www.openphacts.org/units/Nanomolar,403192,=,1,1,=,,IC50,nM,,63.1,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,Log IC50,,UO_0000065,,-7.2
,,12148177,[],CHEMBL2184468,Antagonist activity at human P2X1 receptor by cell-based calcium influx assay,F,,,BAO_0000190,BAO_0000219,cell-based format,OC1(c2ccccc2)c2ccccc2N(Cc2ccccc2)c2ccccc21,,,CHEMBL2177033,J Med Chem,2012,,CHEMBL2180149,,CHEMBL2180149,6.22,0,http://www.openphacts.org/units/Nanomolar,1753342,=,1,1,=,,IC50,nM,,602.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.602
,,12148179,[],CHEMBL2184468,Antagonist activity at human P2X1 receptor by cell-based calcium influx assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(OCc1ccccc1)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012,,CHEMBL2180137,,CHEMBL2180137,5.19,0,http://www.openphacts.org/units/Nanomolar,1753328,=,1,1,=,,IC50,nM,,6520.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,6.52
,,12148181,[],CHEMBL2184468,Antagonist activity at human P2X1 receptor by cell-based calcium influx assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)C(=O)N1c2ccccc2Oc2ccccc21,,,CHEMBL2177033,J Med Chem,2012,,CHEMBL2180174,,CHEMBL2180174,5.70,0,http://www.openphacts.org/units/Nanomolar,1753368,=,1,1,=,,IC50,nM,,2020.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,2.02
,,13278565,[],CHEMBL2379686,Antagonist activity at P2X1 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ncc(COP(=O)(O)O)c(C=O)c1O,,,CHEMBL2375299,Bioorg Med Chem,2013,"{'bei': '20.23', 'le': '0.43', 'lle': '4.48', 'sei': '4.28'}",CHEMBL82202,PYRIDOXAL PHOSPHATE ANHYDROUS,CHEMBL82202,5.00,0,http://www.openphacts.org/units/Nanomolar,1890452,=,1,1,=,,IC50,nM,,10000.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,10.0
,,13880433,[],CHEMBL3107657,"Antagonist activity at P2X1 receptor in HEK293 cells assessed as alpha, beta-methylene ATP-induced calcium flux by FLIPR assay",B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1)c1ccccc12,,,CHEMBL3102727,J Med Chem,2013,"{'bei': '10.49', 'le': '0.20', 'lle': '-1.96', 'sei': '10.20'}",CHEMBL3104636,,CHEMBL3104636,5.80,0,http://www.openphacts.org/units/Nanomolar,1959653,=,1,1,=,,IC50,nM,,1600.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,1.6
,,13885083,[],CHEMBL3108480,Antagonist activity at human P2X1 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(C(=O)N1c2ccccc2C=Cc2ccccc21)C(C)C,,,CHEMBL3102848,Bioorg Med Chem,2014,"{'bei': '16.46', 'le': '0.30', 'lle': '-0.28', 'sei': '22.40'}",CHEMBL3103385,,CHEMBL3103385,5.27,0,http://www.openphacts.org/units/Nanomolar,1958083,=,1,1,=,,IC50,nM,,5320.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,5.32
,,13885084,[],CHEMBL3108480,Antagonist activity at human P2X1 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)C(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL3102848,Bioorg Med Chem,2014,"{'bei': '16.67', 'le': '0.30', 'lle': '-0.21', 'sei': '22.68'}",CHEMBL3103375,,CHEMBL3103375,5.34,0,http://www.openphacts.org/units/Nanomolar,1958073,=,1,1,=,,IC50,nM,,4550.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,4.55
,,14726807,[],CHEMBL3292927,Antagonist activity at P2X1 receptor (unknown origin) by FLIPR assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)CN1CCC2(CC1)CN(c1ccccc1NC(=O)Nc1nc3ccc(Cl)nc3s1)c1c(O)ccc(Cl)c12,,,CHEMBL3286275,Bioorg Med Chem Lett,2014,"{'bei': '11.03', 'le': '0.22', 'lle': '-1.14', 'sei': '7.20'}",CHEMBL3263056,,CHEMBL3263056,6.75,0,http://www.openphacts.org/units/Nanomolar,2114296,=,1,1,=,,IC50,nM,,180.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,nM,UO_0000065,,180.0
,,18416680,[],CHEMBL4153213,Antagonist activity at human P2X1 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced calcium flux measured for 30 secs at 0.4 secs intervals by Flou-4-AM dye based fluorescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C)c2)c1,,,CHEMBL4152208,Eur J Med Chem,2018,"{'bei': '4.14', 'le': None, 'lle': None, 'sei': None}",CHEMBL265502,SURAMIN,CHEMBL265502,5.37,1,http://www.openphacts.org/units/Nanomolar,3056594,=,1,1,=,,IC50,nM,,4300.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,4.3
,,19450862,[],CHEMBL4433702,Antagonist activity at human P2X1R transfected in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx,B,,,BAO_0000190,BAO_0000219,cell-based format,N.N.N.N.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H]2OC3(CCCCC3)O[C@H]21,,,CHEMBL4433213,ACS Med Chem Lett,2019,"{'bei': '8.67', 'le': '0.19', 'lle': '4.00', 'sei': '1.98'}",CHEMBL4525343,,CHEMBL4597064,5.09,0,http://www.openphacts.org/units/Nanomolar,3249783,=,1,1,=,,IC50,nM,,8060.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,8.06
,,19474502,[],CHEMBL4479311,Antagonist activity at human P2X1 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx preincubated for 30 mins prior to ATP-stimulation by calcium influx assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C)c2)c1,,,CHEMBL4477234,J Med Chem,2016,"{'bei': '4.14', 'le': None, 'lle': None, 'sei': None}",CHEMBL265502,SURAMIN,CHEMBL265502,5.37,0,http://www.openphacts.org/units/Nanomolar,3256521,=,1,1,=,,IC50,nM,,4270.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,4.27
,,20648729,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N[C@H](Cc1cscn1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1)c1nc2ccccc2[nH]1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '11.99', 'le': '0.23', 'lle': '3.35', 'sei': '4.50'}",CHEMBL190141,,CHEMBL190141,6.30,0,http://www.openphacts.org/units/Nanomolar,3475702,=,1,1,=,,IC50,nM,,496.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.496
,,20648730,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2S(=O)(=O)[O-])cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2S(=O)(=O)[O-])c1)Nc1cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2S(=O)(=O)[O-])cc(C(=O)Nc2ccc(S(=O)(=O)[O-])cc2S(=O)(=O)[O-])c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,CHEMBL4613266,J Med Chem,2020,"{'bei': '4.99', 'le': None, 'lle': None, 'sei': None}",CHEMBL1253351,,CHEMBL1615557,6.63,0,http://www.openphacts.org/units/Nanomolar,3475703,=,1,1,=,,IC50,nM,,236.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.236
,,20648731,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '20.11', 'le': '0.42', 'lle': '2.38', 'sei': '15.64'}",CHEMBL536151,IMD-0354,CHEMBL536151,7.72,0,http://www.openphacts.org/units/Nanomolar,3475704,=,1,1,=,,IC50,nM,,19.2,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.0192
,,20648732,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '16.97', 'le': '0.34', 'lle': '0.67', 'sei': '19.43'}",CHEMBL2313113,,CHEMBL2313113,5.65,0,http://www.openphacts.org/units/Nanomolar,3475705,=,1,1,=,,IC50,nM,,2220.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,2.22
,,20648734,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '20.37', 'le': '0.40', 'lle': '2.43', 'sei': '14.42'}",CHEMBL461542,,CHEMBL461542,7.11,0,http://www.openphacts.org/units/Nanomolar,3475707,=,1,1,=,,IC50,nM,,76.9,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.0769
,,20648737,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1[N+](=O)[O-],,,CHEMBL4613266,J Med Chem,2020,"{'bei': '13.39', 'le': '0.27', 'lle': '0.19', 'sei': '7.01'}",CHEMBL4647322,,CHEMBL4647322,5.07,0,http://www.openphacts.org/units/Nanomolar,3475710,=,1,1,=,,IC50,nM,,8600.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,8.6
,,20648738,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccccc1C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '14.37', 'le': '0.28', 'lle': '0.44', 'sei': '9.08'}",CHEMBL4567302,,CHEMBL4567302,5.00,0,http://www.openphacts.org/units/Nanomolar,3475711,=,1,1,=,,IC50,nM,,9930.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,9.93
,,20648740,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cccc(O)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '15.20', 'le': '0.30', 'lle': '0.63', 'sei': '10.76'}",CHEMBL4637064,,CHEMBL4637064,5.31,0,http://www.openphacts.org/units/Nanomolar,3475713,=,1,1,=,,IC50,nM,,4910.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,4.91
,,20648741,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cccc(Cl)c1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '18.86', 'le': '0.40', 'lle': '1.90', 'sei': '14.67'}",CHEMBL2338695,,CHEMBL2338695,7.24,0,http://www.openphacts.org/units/Nanomolar,3475714,=,1,1,=,,IC50,nM,,58.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.058
,,20648742,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc(Cl)cc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '19.90', 'le': '0.42', 'lle': '2.30', 'sei': '15.48'}",CHEMBL2338696,,CHEMBL2338696,7.64,0,http://www.openphacts.org/units/Nanomolar,3475715,=,1,1,=,,IC50,nM,,23.1,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.0231
,,20648743,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cccc(C(F)(F)F)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '12.82', 'le': '0.26', 'lle': '-0.86', 'sei': '17.68'}",CHEMBL4638155,,CHEMBL4638155,5.14,0,http://www.openphacts.org/units/Nanomolar,3475716,=,1,1,=,,IC50,nM,,7180.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,7.18
,,20648744,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(O)c(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '18.24', 'le': '0.36', 'lle': '1.64', 'sei': '13.43'}",CHEMBL2313115,,CHEMBL2313115,6.63,0,http://www.openphacts.org/units/Nanomolar,3475717,=,1,1,=,,IC50,nM,,236.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.236
,,20648745,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(O)c(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '16.14', 'le': '0.32', 'lle': '1.43', 'sei': '10.45'}",CHEMBL2313119,,CHEMBL2313119,6.12,0,http://www.openphacts.org/units/Nanomolar,3475718,=,1,1,=,,IC50,nM,,755.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.755
,,20648746,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc([N+](=O)[O-])ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '14.20', 'le': '0.28', 'lle': '1.01', 'sei': '6.05'}",CHEMBL2313122,,CHEMBL2313122,5.60,0,http://www.openphacts.org/units/Nanomolar,3475719,=,1,1,=,,IC50,nM,,2530.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,2.53
,,20648747,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(F)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '15.74', 'le': '0.32', 'lle': '0.96', 'sei': '11.72'}",CHEMBL2313116,,CHEMBL2313116,5.78,0,http://www.openphacts.org/units/Nanomolar,3475720,=,1,1,=,,IC50,nM,,1660.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,1.66
,,20648748,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(O)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '14.97', 'le': '0.30', 'lle': '1.08', 'sei': '7.86'}",CHEMBL4643605,,CHEMBL4643605,5.47,0,http://www.openphacts.org/units/Nanomolar,3475721,=,1,1,=,,IC50,nM,,3410.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,3.41
,,20648749,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1c(O)cccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '13.96', 'le': '0.28', 'lle': '0.71', 'sei': '7.33'}",CHEMBL4635672,,CHEMBL4635672,5.10,0,http://www.openphacts.org/units/Nanomolar,3475722,=,1,1,=,,IC50,nM,,8000.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,8.0
,,20648750,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cccc(F)c1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '19.47', 'le': '0.39', 'lle': '2.33', 'sei': '14.50'}",CHEMBL4644398,,CHEMBL4644398,7.15,0,http://www.openphacts.org/units/Nanomolar,3475723,=,1,1,=,,IC50,nM,,70.6,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.0706
,,20648751,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '17.02', 'le': '0.34', 'lle': '1.19', 'sei': '12.54'}",CHEMBL4639803,,CHEMBL4639803,6.18,0,http://www.openphacts.org/units/Nanomolar,3475724,=,1,1,=,,IC50,nM,,655.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.655
,,20648752,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cccc([N+](=O)[O-])c1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '15.37', 'le': '0.31', 'lle': '1.47', 'sei': '6.55'}",CHEMBL3628655,,CHEMBL3628655,6.06,0,http://www.openphacts.org/units/Nanomolar,3475725,=,1,1,=,,IC50,nM,,869.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.869
,,20648753,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc2ccccc2c1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '16.20', 'le': '0.32', 'lle': '0.63', 'sei': '13.11'}",CHEMBL2338686,,CHEMBL2338686,6.47,0,http://www.openphacts.org/units/Nanomolar,3475726,=,1,1,=,,IC50,nM,,341.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.341
,,20648755,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccncc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '15.08', 'le': '0.30', 'lle': '1.20', 'sei': '8.49'}",CHEMBL4636258,,CHEMBL4636258,5.28,0,http://www.openphacts.org/units/Nanomolar,3475728,=,1,1,=,,IC50,nM,,5250.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,5.25
,,20648759,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '22.30', 'le': '0.46', 'lle': '2.72', 'sei': '14.27'}",CHEMBL589733,,CHEMBL589733,7.04,0,http://www.openphacts.org/units/Nanomolar,3475732,=,1,1,=,,IC50,nM,,91.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.091
,,20648760,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '20.93', 'le': '0.40', 'lle': '2.23', 'sei': '11.93'}",CHEMBL2104794,SALFLUVERINE,CHEMBL2104794,5.89,0,http://www.openphacts.org/units/Nanomolar,3475733,=,1,1,=,,IC50,nM,,1300.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,1.3
,,20648762,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccc(C(F)(F)F)cc1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '23.49', 'le': '0.48', 'lle': '3.10', 'sei': '15.04'}",CHEMBL2088014,,CHEMBL2088014,7.42,0,http://www.openphacts.org/units/Nanomolar,3475735,=,1,1,=,,IC50,nM,,38.3,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.0383
,,20648763,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccc(Cl)cc1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '23.75', 'le': '0.51', 'lle': '2.75', 'sei': '13.58'}",CHEMBL2088012,,CHEMBL2088012,6.70,0,http://www.openphacts.org/units/Nanomolar,3475736,=,1,1,=,,IC50,nM,,199.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.199
,,20648764,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccc(F)cc1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '22.74', 'le': '0.46', 'lle': '2.60', 'sei': '12.25'}",CHEMBL2312822,,CHEMBL2312822,6.04,0,http://www.openphacts.org/units/Nanomolar,3475737,=,1,1,=,,IC50,nM,,907.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.907
,,20648767,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc([N+](=O)[O-])cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '20.79', 'le': '0.43', 'lle': '3.28', 'sei': '8.11'}",CHEMBL4640175,,CHEMBL4640175,7.50,0,http://www.openphacts.org/units/Nanomolar,3475740,=,1,1,=,,IC50,nM,,31.6,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.0316
,,20648768,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(C)cc(NC(=O)c2cc(Cl)ccc2O)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '23.54', 'le': '0.47', 'lle': '2.58', 'sei': '13.16'}",CHEMBL2178702,,CHEMBL2178702,6.49,0,http://www.openphacts.org/units/Nanomolar,3475741,=,1,1,=,,IC50,nM,,323.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.323
,,20648769,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(Cl)cc(Cl)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '23.80', 'le': '0.54', 'lle': '2.93', 'sei': '15.27'}",CHEMBL2179173,,CHEMBL2179173,7.53,0,http://www.openphacts.org/units/Nanomolar,3475742,=,1,1,=,,IC50,nM,,29.3,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.0293
,,20648770,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(NC(=O)c2cc(Cl)ccc2O)cc(OC)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '19.62', 'le': '0.39', 'lle': '2.72', 'sei': '8.91'}",CHEMBL4634436,,CHEMBL4634436,6.04,0,http://www.openphacts.org/units/Nanomolar,3475743,=,1,1,=,,IC50,nM,,915.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.915
,,20648771,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(F)cc(F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '25.72', 'le': '0.52', 'lle': '3.72', 'sei': '14.79'}",CHEMBL2179174,,CHEMBL2179174,7.30,0,http://www.openphacts.org/units/Nanomolar,3475744,=,1,1,=,,IC50,nM,,50.5,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.0505
,,20648773,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '15.88', 'le': '0.32', 'lle': '2.25', 'sei': '3.95'}",CHEMBL4647253,,CHEMBL4647253,5.36,0,http://www.openphacts.org/units/Nanomolar,3475746,=,1,1,=,,IC50,nM,,4350.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,4.35
,,20648774,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc([N+](=O)[O-])c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '23.11', 'le': '0.46', 'lle': '3.55', 'sei': '7.32'}",CHEMBL2088009,,CHEMBL2088009,6.76,0,http://www.openphacts.org/units/Nanomolar,3475747,=,1,1,=,,IC50,nM,,172.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.172
,,20648776,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccc(NC(=O)c2cc(Cl)ccc2O)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '23.04', 'le': '0.45', 'lle': '3.11', 'sei': '8.59'}",CHEMBL2179168,,CHEMBL2179168,6.28,0,http://www.openphacts.org/units/Nanomolar,3475749,=,1,1,=,,IC50,nM,,522.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.522
,,20648777,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc(Cl)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '25.24', 'le': '0.54', 'lle': '3.17', 'sei': '14.44'}",CHEMBL2088011,,CHEMBL2088011,7.12,0,http://www.openphacts.org/units/Nanomolar,3475750,=,1,1,=,,IC50,nM,,75.6,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.0756
,,20648778,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc(S(=O)(=O)C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '17.05', 'le': '0.37', 'lle': '2.88', 'sei': '7.76'}",CHEMBL4648128,,CHEMBL4648128,6.47,0,http://www.openphacts.org/units/Nanomolar,3475751,=,1,1,=,,IC50,nM,,335.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.335
,,20648779,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1cccc(NC(=O)c2cc(Cl)ccc2O)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '20.56', 'le': '0.41', 'lle': '1.65', 'sei': '12.66'}",CHEMBL2179170,,CHEMBL2179170,6.25,0,http://www.openphacts.org/units/Nanomolar,3475752,=,1,1,=,,IC50,nM,,567.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.567
,,20648780,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,C#Cc1cccc(NC(=O)c2cc(Cl)ccc2O)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '21.62', 'le': '0.42', 'lle': '2.59', 'sei': '11.91'}",CHEMBL2179166,,CHEMBL2179166,5.87,0,http://www.openphacts.org/units/Nanomolar,3475753,=,1,1,=,,IC50,nM,,1340.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,1.34
,,20648781,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc(OC(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '15.43', 'le': '0.32', 'lle': '0.92', 'sei': '8.74'}",CHEMBL4636039,,CHEMBL4636039,5.12,0,http://www.openphacts.org/units/Nanomolar,3475754,=,1,1,=,,IC50,nM,,7620.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,7.62
,,20648783,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cccc(Br)c1)c1ccccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '19.07', 'le': '0.45', 'lle': '2.16', 'sei': '11.29'}",CHEMBL4641171,,CHEMBL4641171,5.57,0,http://www.openphacts.org/units/Nanomolar,3475756,=,1,1,=,,IC50,nM,,2690.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,2.69
,,20648784,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc([N+](=O)[O-])cc(C(F)(F)F)c1)c1cccc(Cl)c1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '18.46', 'le': '0.38', 'lle': '2.44', 'sei': '7.20'}",CHEMBL4637528,,CHEMBL4637528,6.66,0,http://www.openphacts.org/units/Nanomolar,3475757,=,1,1,=,,IC50,nM,,219.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.219
,,20648788,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CNc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '14.45', 'le': '0.30', 'lle': '0.37', 'sei': '11.65'}",CHEMBL4644509,,CHEMBL4644509,5.75,0,http://www.openphacts.org/units/Nanomolar,3475761,=,1,1,=,,IC50,nM,,1790.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,1.79
,,20648790,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,Oc1ccc(Cl)cc1CNc1cc(C(F)(F)F)cc(C(F)(F)F)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '14.66', 'le': '0.31', 'lle': '-0.28', 'sei': '16.79'}",CHEMBL2313128,,CHEMBL2313128,5.42,0,http://www.openphacts.org/units/Nanomolar,3475763,=,1,1,=,,IC50,nM,,3820.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,3.82
,,20648791,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '14.62', 'le': '0.31', 'lle': '0.81', 'sei': '11.79'}",CHEMBL2313134,,CHEMBL2313134,5.82,0,http://www.openphacts.org/units/Nanomolar,3475764,=,1,1,=,,IC50,nM,,1530.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,1.53
,,20648792,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C(=O)c1cc(Cl)ccc1O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '13.56', 'le': '0.28', 'lle': '0.03', 'sei': '13.30'}",CHEMBL4641185,,CHEMBL4641185,5.39,0,http://www.openphacts.org/units/Nanomolar,3475765,=,1,1,=,,IC50,nM,,4060.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,4.06
,,20648793,[],CHEMBL4615154,Antagonist activity at non-desensitizing human P2X1 receptor ( P2X2/P2X1 chimera) expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx pre-incubated for 30 mins before ATP stimulation by FLIPR assay relative to control,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '15.15', 'le': '0.33', 'lle': '1.48', 'sei': '9.57'}",CHEMBL2313133,,CHEMBL2313133,6.36,0,http://www.openphacts.org/units/Nanomolar,3475766,=,1,1,=,,IC50,nM,,439.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.439
,,20648873,[],CHEMBL4615164,Antagonist activity P2X1 receptor in Apyrase pre-treated human platelets assessed as inhibition of collagen-induced platelet aggregation pre-incubated for 30 mins before collagen stimulation by aggregometry,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '16.27', 'le': '0.34', 'lle': '0.90', 'sei': '12.66'}",CHEMBL536151,IMD-0354,CHEMBL536151,6.24,0,http://www.openphacts.org/units/Nanomolar,3475704,=,1,1,=,,IC50,nM,,570.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.57
,,20648874,[],CHEMBL4615164,Antagonist activity P2X1 receptor in Apyrase pre-treated human platelets assessed as inhibition of collagen-induced platelet aggregation pre-incubated for 30 mins before collagen stimulation by aggregometry,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '17.04', 'le': '0.34', 'lle': '0.70', 'sei': '19.51'}",CHEMBL2313113,,CHEMBL2313113,5.68,0,http://www.openphacts.org/units/Nanomolar,3475705,=,1,1,=,,IC50,nM,,2100.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,2.1
,,20648875,[],CHEMBL4615164,Antagonist activity P2X1 receptor in Apyrase pre-treated human platelets assessed as inhibition of collagen-induced platelet aggregation pre-incubated for 30 mins before collagen stimulation by aggregometry,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc(Cl)cc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '15.49', 'le': '0.32', 'lle': '0.60', 'sei': '12.05'}",CHEMBL2338696,,CHEMBL2338696,5.94,0,http://www.openphacts.org/units/Nanomolar,3475715,=,1,1,=,,IC50,nM,,1140.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,1.14
,,20648877,[],CHEMBL4615164,Antagonist activity P2X1 receptor in Apyrase pre-treated human platelets assessed as inhibition of collagen-induced platelet aggregation pre-incubated for 30 mins before collagen stimulation by aggregometry,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(Cl)cc(Cl)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '17.43', 'le': '0.40', 'lle': '0.92', 'sei': '11.19'}",CHEMBL2179173,,CHEMBL2179173,5.52,0,http://www.openphacts.org/units/Nanomolar,3475742,=,1,1,=,,IC50,nM,,3030.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,3.03
,,20648879,[],CHEMBL4615164,Antagonist activity P2X1 receptor in Apyrase pre-treated human platelets assessed as inhibition of collagen-induced platelet aggregation pre-incubated for 30 mins before collagen stimulation by aggregometry,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '13.11', 'le': '0.29', 'lle': '0.62', 'sei': '8.29'}",CHEMBL2313133,,CHEMBL2313133,5.50,0,http://www.openphacts.org/units/Nanomolar,3475766,=,1,1,=,,IC50,nM,,3130.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,3.13
,,20648880,[],CHEMBL4615165,Antagonist activity P2X1 receptor in Apyrase pre-treated human platelets assessed as inhibition of TRAP6-induced platelet aggregation pre-incubated for 30 mins before TRAP6 stimulation by aggregometry,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '14.18', 'le': '0.30', 'lle': '0.10', 'sei': '11.03'}",CHEMBL536151,IMD-0354,CHEMBL536151,5.44,0,http://www.openphacts.org/units/Nanomolar,3475704,=,1,1,=,,IC50,nM,,3640.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,3.64
,,20648881,[],CHEMBL4615165,Antagonist activity P2X1 receptor in Apyrase pre-treated human platelets assessed as inhibition of TRAP6-induced platelet aggregation pre-incubated for 30 mins before TRAP6 stimulation by aggregometry,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '15.77', 'le': '0.31', 'lle': '0.27', 'sei': '18.06'}",CHEMBL2313113,,CHEMBL2313113,5.25,0,http://www.openphacts.org/units/Nanomolar,3475705,=,1,1,=,,IC50,nM,,5570.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,5.57
,,20648882,[],CHEMBL4615165,Antagonist activity P2X1 receptor in Apyrase pre-treated human platelets assessed as inhibition of TRAP6-induced platelet aggregation pre-incubated for 30 mins before TRAP6 stimulation by aggregometry,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc(Cl)cc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '13.86', 'le': '0.29', 'lle': '-0.02', 'sei': '10.78'}",CHEMBL2338696,,CHEMBL2338696,5.32,0,http://www.openphacts.org/units/Nanomolar,3475715,=,1,1,=,,IC50,nM,,4800.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,4.8
,,20648887,[],CHEMBL4615166,Antagonist activity P2X1 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation pre-incubated for 30 mins before ADP stimulation by aggregometry,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '13.88', 'le': '0.29', 'lle': '-0.01', 'sei': '10.79'}",CHEMBL536151,IMD-0354,CHEMBL536151,5.33,0,http://www.openphacts.org/units/Nanomolar,3475704,=,1,1,=,,IC50,nM,,4730.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,4.73
,,20648889,[],CHEMBL4615166,Antagonist activity P2X1 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation pre-incubated for 30 mins before ADP stimulation by aggregometry,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccc(Cl)cc1O,,,CHEMBL4613266,J Med Chem,2020,"{'bei': '13.71', 'le': '0.29', 'lle': '-0.08', 'sei': '10.67'}",CHEMBL2338696,,CHEMBL2338696,5.26,0,http://www.openphacts.org/units/Nanomolar,3475715,=,1,1,=,,IC50,nM,,5470.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,5.47
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24696956,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5106922,"Antagonist activity at human P2X1R transfected in CHO-K1 cells preincubated for 30 mins followed by alpha,beta-meATP addition by luminescence based assay",B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@H]2OC3(O[C@H]21)C([N+](=O)[O-])=CC([N+](=O)[O-])C=C3[N+](=O)[O-],,,CHEMBL5104186,J Med Chem,2022,"{'bei': '9.64', 'le': '0.21', 'lle': '7.81', 'sei': '1.79'}",CHEMBL337395,,CHEMBL337395,6.92,0,http://www.openphacts.org/units/Nanomolar,3851065,=,1,1,=,,IC50,nM,,120.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,0.12
"{'action_type': 'AGONIST', 'description': 'Binds to and activates a receptor, often mimicking the effect of the endogenous ligand', 'parent_type': 'POSITIVE MODULATOR'}",,24770218,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126047,Agonist activity at human P2X1R expressing CHO cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1N,,,CHEMBL5120960,J Med Chem,2022,"{'bei': '10.25', 'le': '0.23', 'lle': '6.85', 'sei': '1.82'}",CHEMBL4582937,,CHEMBL4582937,5.19,0,http://www.openphacts.org/units/Nanomolar,3864900,=,1,1,=,,IC50,nM,,6456.54,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,pIC50,,UO_0000065,,5.19
"{'action_type': 'AGONIST', 'description': 'Binds to and activates a receptor, often mimicking the effect of the endogenous ligand', 'parent_type': 'POSITIVE MODULATOR'}",,24770221,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126047,Agonist activity at human P2X1R expressing CHO cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(Cl)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL5120960,J Med Chem,2022,"{'bei': '16.05', 'le': '0.37', 'lle': '9.01', 'sei': '3.34'}",CHEMBL1160555,,CHEMBL1160555,8.45,0,http://www.openphacts.org/units/Nanomolar,3864903,=,1,1,=,,IC50,nM,,3.548,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,pIC50,,UO_0000065,,8.45
"{'action_type': 'AGONIST', 'description': 'Binds to and activates a receptor, often mimicking the effect of the endogenous ligand', 'parent_type': 'POSITIVE MODULATOR'}",,24770222,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5126047,Agonist activity at human P2X1R expressing CHO cells assessed as reduction in intracellular Ca2+ influx pretreated with Fluo-4 for 1 hr followed by compound addition and further incubated for 30 mins in presence of ATP by multimode plate reader analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(S)ncnc32)[C@H](O)[C@@H]1O,,,CHEMBL5120960,J Med Chem,2022,"{'bei': '11.10', 'le': '0.26', 'lle': '6.74', 'sei': '2.30'}",CHEMBL4583478,,CHEMBL4583478,5.82,0,http://www.openphacts.org/units/Nanomolar,3864904,=,1,1,=,,IC50,nM,,1513.56,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,pIC50,,UO_0000065,,5.82
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24773442,[],CHEMBL5127321,Inhibition of P2X1 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ncnc2c1ncn2[C@H]1C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O1,,,CHEMBL5126515,Eur J Med Chem,2022,"{'bei': '13.97', 'le': '0.30', 'lle': '6.20', 'sei': '2.99'}",CHEMBL129841,,CHEMBL129841,5.94,1,http://www.openphacts.org/units/Nanomolar,3865839,=,1,1,=,,IC50,nM,,1150.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,uM,UO_0000065,,1.15
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,26004656,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'TIME', 'units': 'min', 'value': '30.0'}]",CHEMBL5554621,Antagonist activity at human P2X1 receptor expressed in 1321N1 cells incubated for 30 mins in presence of ATP by Fluo-4 dye based microplate reader assay,B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(N2CCN(C(N)=O)CC2)nc2nc(C3CC3)nn12)c1ccc2ccccc2c1,,,CHEMBL5550216,J Med Chem,2024,"{'bei': '11.76', 'le': '0.22', 'lle': '1.84', 'sei': '5.13'}",CHEMBL5594973,,CHEMBL5594973,5.37,0,http://www.openphacts.org/units/Nanomolar,4087789,=,1,1,=,,IC50,nM,,4280.0,CHEMBL2094,Homo sapiens,P2X purinoceptor 1,9606,,,IC50,nM,UO_0000065,,4280.0
